Clinical Trial Update: Identification of Prognostic and Predictive Biomarkers of Toxicity in Patients With Malignant Pleural Mesothelioma and Treated With High Doses of Radiotherapy (MESORTIBO)

View source ↗

Summary

A clinical trial (MESORTIBO) investigating prognostic and predictive biomarkers of toxicity in patients with malignant pleural mesothelioma treated with high-do…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Mesothelioma

Snippet

Sponsor: Centro di Riferimento Oncologico - Aviano | Conditions: Pleural Mesothelioma Malignant | Status: RECRUITING